John D Reveille MD
Professor, Internal Medicine, University of Texas Medical School, Houston
Join to View Full Profile
6410 Fannin St600Houston, TX 77030
Phone+1 832-325-7191
Fax+1 713-512-2246
Dr. Reveille is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 1980 - 1983
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1977 - 1980- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
TX State Medical License 1987 - 2027
FL State Medical License 1978 - 1989
AL State Medical License 1983 - 1987
MD State Medical License 1980 - 1983
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2017
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Genetics of Ankylosing Spondylitis Start of enrollment: 1999 Sep 01
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
Publications & Presentations
PubMed
- Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.John D Reveille, Martin Rudwaleit, Proton Rahman, Jose A Maldonado-Cocco, Marina Magrey
Rheumatology and Therapy. 2026-02-01 - Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis.Mark C Hwang, Seokhun Kim, Shervin Assassi, Reyna Chavez, Joyce Samuel
Rheumatology. 2025-12-01 - 1 citationsGlobal epidemiology of spondyloarthritis.John D Reveille, Lihi Eder, Nelly Ziade, Percival D Sampaio-Barros, Tae-Hwan Kim
Nature Reviews. Rheumatology. 2025-10-01
Press Mentions
- Clinical Pearls: What We Know About Nonradiographic Axial SpondyloarthritisJune 16th, 2020
How to Assemble a Care Team for Axial SpondyloarthritisFebruary 27th, 2024
Grant Support
- Studies Of HLA Region Genomics In Systemic Sclerosis And Ankylosing SpondyilitisNational Institute Of Allergy And Infectious Diseases2010–2011
- Pre-And Postdoctoral Training In The Rheumatic DiseasesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2011
- Genotyping CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2010
- Genetics And Ankylosing Spondylitis (AS) PathogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
- A Comprehensive Model Of Severity In Outcomes In Ankylosing SpondylitisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
Professional Memberships
- Member
- Research Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
